Sporikova, Z., Koudelakova, V., Trojanec, R. & Hajduch, M. Genetic Markers in Triple-Detrimental Breast Most cancers. Clin Breast Most cancers 18, e841–e850 (2018).Article
...
Enhertu: A Promising New Drug for HER2-Constructive CancersEnhertu (trastuzumab deruxtecan), a HER2-targeting antibody-drug conjugate (ADC) bearing a deruxtecan (TOP1 inhibitor) warhead, was developed...